C142H166N30O13 — CID 161037161
4-[5-(cyclohexylamino)-7-(oxan-4-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]-N-cyclopropyl-2-methylbenzamide;4-[5-(cyclopentylamino)-7-(oxan-4-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]-N-cyclopropyl-2-methylbenzamide;N-cyclopropyl-2-methyl-4-[7-(2-morpholin-4-ylethylamino)-5-phenoxypyrazolo[1,5-a]pyrimidin-3-yl]benzamide;N-cyclopropyl-2-methyl-4-[7-(oxan-4-ylmethylamino)-5-pyridin-3-yloxypyrazolo[1,5-a]pyrimidin-3-yl]benzamide;N-cyclopropyl-4-[7-(2-morpholin-4-ylethylamino)-5-phenoxypyrazolo[1,5-a]pyrimidin-3-yl]benzamide (PubChem CID 161037161) has the molecular formula C142H166N30O13 and a molecular weight of 2501.09 g/mol. Its IUPAC name is 4-[5-(cyclohexylamino)-7-(oxan-4-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]-N-cyclopropyl-2-methylbenzamide;4-[5-(cyclopentylamino)-7-(oxan-4-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]-N-cyclopropyl-2-methylbenzamide;N-cyclopropyl-2-methyl-4-[7-(2-morpholin-4-ylethylamino)-5-phenoxypyrazolo[1,5-a]pyrimidin-3-yl]benzamide;N-cyclopropyl-2-methyl-4-[7-(oxan-4-ylmethylamino)-5-pyridin-3-yloxypyrazolo[1,5-a]pyrimidin-3-yl]benzamide;N-cyclopropyl-4-[7-(2-morpholin-4-ylethylamino)-5-phenoxypyrazolo[1,5-a]pyrimidin-3-yl]benzamide.
| Compound Name | 4-[5-(cyclohexylamino)-7-(oxan-4-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]-N-cyclopropyl-2-methylbenzamide;4-[5-(cyclopentylamino)-7-(oxan-4-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]-N-cyclopropyl-2-methylbenzamide;N-cyclopropyl-2-methyl-4-[7-(2-morpholin-4-ylethylamino)-5-phenoxypyrazolo[1,5-a]pyrimidin-3-yl]benzamide;N-cyclopropyl-2-methyl-4-[7-(oxan-4-ylmethylamino)-5-pyridin-3-yloxypyrazolo[1,5-a]pyrimidin-3-yl]benzamide;N-cyclopropyl-4-[7-(2-morpholin-4-ylethylamino)-5-phenoxypyrazolo[1,5-a]pyrimidin-3-yl]benzamide |
|---|---|
| PubChem CID | 161037161 |
| Molecular Formula | C142H166N30O13 |
| Molecular Weight | 2501.09 g/mol |
| Exact Mass | 2499.33 |
| IUPAC Name | 4-[5-(cyclohexylamino)-7-(oxan-4-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]-N-cyclopropyl-2-methylbenzamide;4-[5-(cyclopentylamino)-7-(oxan-4-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]-N-cyclopropyl-2-methylbenzamide;N-cyclopropyl-2-methyl-4-[7-(2-morpholin-4-ylethylamino)-5-phenoxypyrazolo[1,5-a]pyrimidin-3-yl]benzamide;N-cyclopropyl-2-methyl-4-[7-(oxan-4-ylmethylamino)-5-pyridin-3-yloxypyrazolo[1,5-a]pyrimidin-3-yl]benzamide;N-cyclopropyl-4-[7-(2-morpholin-4-ylethylamino)-5-phenoxypyrazolo[1,5-a]pyrimidin-3-yl]benzamide |
| SMILES | Cc1cc(-c2cnn3c(NCC4CCOCC4)cc(NC4CCCC4)nc23)ccc1C(=O)NC1CC1.Cc1cc(-c2cnn3c(NCC4CCOCC4)cc(NC4CCCCC4)nc23)ccc1C(=O)NC1CC1.Cc1cc(-c2cnn3c(NCC4CCOCC4)cc(Oc4cccnc4)nc23)ccc1C(=O)NC1CC1.Cc1cc(-c2cnn3c(NCCN4CCOCC4)cc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1.O=C(NC1CC1)c1ccc(-c2cnn3c(NCCN4CCOCC4)cc(Oc4ccccc4)nc23)cc1 |
| InChI | InChI=1S/C29H32N6O3.C29H38N6O2.2C28H30N6O3.C28H36N6O2/c1-20-17-21(7-10-24(20)29(36)32-22-8-9-22)25-19-31-35-26(30-11-12-34-13-15-37-16-14-34)18-27(33-28(25)35)38-23-5-3-2-4-6-23;1-19-15-21(7-10-24(19)29(36)33-23-8-9-23)25-18-31-35-27(30-17-20-11-13-37-14-12-20)16-26(34-28(25)35)32-22-5-3-2-4-6-22;1-18-13-20(4-7-23(18)28(35)32-21-5-6-21)24-17-31-34-25(30-15-19-8-11-36-12-9-19)14-26(33-27(24)34)37-22-3-2-10-29-16-22;35-28(31-22-10-11-22)21-8-6-20(7-9-21)24-19-30-34-25(29-12-13-33-14-16-36-17-15-33)18-26(32-27(24)34)37-23-4-2-1-3-5-23;1-18-14-20(6-9-23(18)28(35)32-22-7-8-22)24-17-30-34-26(29-16-19-10-12-36-13-11-19)15-25(33-27(24)34)31-21-4-2-3-5-21/h2-7,10,17-19,22,30H,8-9,11-16H2,1H3,(H,32,36);7,10,15-16,18,20,22-23,30H,2-6,8-9,11-14,17H2,1H3,(H,32,34)(H,33,36);2-4,7,10,13-14,16-17,19,21,30H,5-6,8-9,11-12,15H2,1H3,(H,32,35);1-9,18-19,22,29H,10-17H2,(H,31,35);6,9,14-15,17,19,21-22,29H,2-5,7-8,10-13,16H2,1H3,(H,31,33)(H,32,35) |
| InChIKey | UAKBESJAQDNUGU-UHFFFAOYSA-N |
| XLogP | 22.55 |
| TPSA | 473.87 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 42 |
| Heavy Atoms | 185 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2501.09 |
| LogP ≤ 5 | 22.55 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 38 |